Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation. (Q35848688)
Jump to navigation
Jump to search
scientific article published on 25 October 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation. |
scientific article published on 25 October 2005 |
Statements
Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation (English)
Malcolm K Brenner
Helen E Heslop
Adrian P Gee
Robert A Krance
George Carrum
Zhuyong Mei
Bambi Grilley
Eric S Yvon
Ettore Biagi
Uday Popat
Aurélie Dutour
Raphaël F Rousseau
Tiffany Lin
25 October 2005
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference